Application 050629
- Type
- NDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 2MG/ML | Yes | Yes |
| 002 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 200MG/100ML | Yes | Yes |
| 003 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 150MG/75ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050629-001 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 |
| N050629-002 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 |
| N050629-003 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N050629-001 | AP |
| N050629-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N050629-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050629-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050629-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050629-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050629-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050629-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050629-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050629-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050629-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N050629-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050629-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N050629-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N050629-002 | AP | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 0069-3030 0069-3032 0069-3031 0069-3034 0069-3033 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 00634b2b-4e48-4178-8877-28582af894ad | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 0069-4004 0069-4026 0069-4015 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | d31d7f58-66d0-4826-b6b5-5914c031965f | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 0069-4031 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0069-4033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78470 | SUPPL | 2024-05-15 |
| 78469 | SUPPL | 2024-05-15 |
| 65072 | SUPPL | 2020-10-29 |
| 64453 | SUPPL | 2020-08-31 |
| 61441 | SUPPL | 2019-12-26 |
| 61393 | SUPPL | 2019-12-23 |
| 59677 | SUPPL | 2019-08-12 |
| 59661 | SUPPL | 2019-08-12 |
| 7906 | SUPPL | 2013-11-06 |
| 17954 | SUPPL | 2013-11-01 |
| 7905 | SUPPL | 2011-09-29 |
| 17953 | SUPPL | 2011-09-26 |
| 7904 | SUPPL | 2010-08-09 |
| 17952 | SUPPL | 2010-07-30 |
| 30189 | SUPPL | 2003-05-30 |
| 7903 | SUPPL | 2003-05-30 |
| 17951 | SUPPL | 2003-05-29 |
| 17950 | SUPPL | 2003-05-13 |
| 39053 | SUPPL | 2002-09-25 |
| 17949 | SUPPL | 2002-09-25 |
| 7902 | SUPPL | 2002-09-25 |
| 7901 | SUPPL | 2002-09-25 |